GE Medical Systems has agreed to work with CADx to distribute two computer-aided detection technologies developed by the Beavercreek, OH, company. The two products, Second Look Digital and Second Look AD, are designed to be integrated with GE's
GE Medical Systems has agreed to work with CADx to distribute two computer-aided detection technologies developed by the Beavercreek, OH, company. The two products, Second Look Digital and Second Look AD, are designed to be integrated with GE's Senographe 2000D full-field digital mammography system. The Second Look AD system is pending approval from the FDA.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.